HY-P99165-1mg
|
MedChemexpress LLC
|
TeprotuMu mab [CAS 1036734-93-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99165-10mg
|
MedChemexpress LLC
|
TeprotuMu mab [CAS 1036734-93-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99165-5mg
|
MedChemexpress LLC
|
TeprotuMu mab [CAS 1036734-93-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99187-1mg
|
MedChemexpress LLC
|
Bococizumab [CAS 1407495-02-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99187-10mg
|
MedChemexpress LLC
|
Bococizumab [CAS 1407495-02-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99187-5mg
|
MedChemexpress LLC
|
Bococizumab [CAS 1407495-02-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99211-1mg
|
MedChemexpress LLC
|
Otelixizumab [CAS 881191-44-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99211-10mg
|
MedChemexpress LLC
|
Otelixizumab [CAS 881191-44-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99211-5mg
|
MedChemexpress LLC
|
Otelixizumab [CAS 881191-44-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99222-1mg
|
MedChemexpress LLC
|
Teplizumab [CAS 876387-05-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99222-10mg
|
MedChemexpress LLC
|
Teplizumab [CAS 876387-05-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99222-5mg
|
MedChemexpress LLC
|
Teplizumab [CAS 876387-05-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P9928-1mg
|
MedChemexpress LLC
|
Alirocumab [CAS 1245916-14-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P9928-10mg
|
MedChemexpress LLC
|
Alirocumab [CAS 1245916-14-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P9928-5mg
|
MedChemexpress LLC
|
Alirocumab [CAS 1245916-14-6]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P9930-1mg
|
MedChemexpress LLC
|
Evolocumab [CAS 1256937-27-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P9930-10mg
|
MedChemexpress LLC
|
Evolocumab [CAS 1256937-27-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P9930-5mg
|
MedChemexpress LLC
|
Evolocumab [CAS 1256937-27-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99357-1mg
|
MedChemexpress LLC
|
Crotedumab [CAS 1452387-69-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-P99357-10mg
|
MedChemexpress LLC
|
Crotedumab [CAS 1452387-69-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-P99357-5mg
|
MedChemexpress LLC
|
Crotedumab [CAS 1452387-69-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-P99359-1mg
|
MedChemexpress LLC
|
Elezanumab [CAS 1791416-49-3]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99359-10mg
|
MedChemexpress LLC
|
Elezanumab [CAS 1791416-49-3]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99359-5mg
|
MedChemexpress LLC
|
Elezanumab [CAS 1791416-49-3]
|
|
Metabolism-protein/nucleotide metabolism
|
|
HY-P99365-1mg
|
MedChemexpress LLC
|
Ravulizumab [CAS 1803171-55-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|